Does TREPROSTINIL Cause Hyperventilation? 44 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 44 reports of Hyperventilation have been filed in association with TREPROSTINIL (TYVASO). This represents 0.1% of all adverse event reports for TREPROSTINIL.
44
Reports of Hyperventilation with TREPROSTINIL
0.1%
of all TREPROSTINIL reports
3
Deaths
20
Hospitalizations
How Dangerous Is Hyperventilation From TREPROSTINIL?
Of the 44 reports, 3 (6.8%) resulted in death, 20 (45.5%) required hospitalization.
Is Hyperventilation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 44 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Hyperventilation?
OMALIZUMAB (112)
ALBUTEROL (108)
METFORMIN (88)
CARBIDOPA\LEVODOPA (84)
PREDNISONE (77)
ADALIMUMAB (75)
ASPIRIN (75)
IBUPROFEN (73)
DULOXETINE (70)
MEPOLIZUMAB (70)
Which TREPROSTINIL Alternatives Have Lower Hyperventilation Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE